Guest guest Posted February 19, 2011 Report Share Posted February 19, 2011 7. LIN ZH, Xin YN, Dong QJ, Wang Q, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis. Hepatology. 2010 Dec 7. doi: 10.1002/hep.24105. http://amedeo.com/p2.php?id=21319189 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 8. KHATTAB MA, Ferenci P, Hadziyannis SJ, Colombo M, et al. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. J Hepatol. 2010. http://amedeo.com/p2.php?id=21316497 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 9. MULLER T, Buch S, Berg T, Hampe J, et al. Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C. J Hepatol. 2011. http://amedeo.com/p2.php?id=21316406 & s=hep & pm=3e5d26a0f9107d3 10. DULTZ G, Kronenberger B, Azizi A, Mihm U, et al. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura. J Hepatol. 2011. http://amedeo.com/p2.php?id=21310200 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available MEULEMAN P, Bukh J, Verhoye L, Farhoudi A, et al. In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus. Hepatology. 2011 Jan 11. doi: 10.1002/hep.24171. http://amedeo.com/p2.php?id=21319203 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 4. STEPANOVA M, Kanwal F, El-Serag HB, Younossi ZM, et al. Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States. Hepatology. 2010 Dec 17. doi: 10.1002/hep.24131. http://amedeo.com/p2.php?id=21319199 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 5. VALENTI L, Rumi M, Galmozzi E, Aghemo A, et al. Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology. 2010 Dec 13. doi: 10.1002/hep.24123. http://amedeo.com/p2.php?id=21319195 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 19, 2011 Report Share Posted February 19, 2011 7. LIN ZH, Xin YN, Dong QJ, Wang Q, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis. Hepatology. 2010 Dec 7. doi: 10.1002/hep.24105. http://amedeo.com/p2.php?id=21319189 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 8. KHATTAB MA, Ferenci P, Hadziyannis SJ, Colombo M, et al. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. J Hepatol. 2010. http://amedeo.com/p2.php?id=21316497 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 9. MULLER T, Buch S, Berg T, Hampe J, et al. Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C. J Hepatol. 2011. http://amedeo.com/p2.php?id=21316406 & s=hep & pm=3e5d26a0f9107d3 10. DULTZ G, Kronenberger B, Azizi A, Mihm U, et al. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura. J Hepatol. 2011. http://amedeo.com/p2.php?id=21310200 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available MEULEMAN P, Bukh J, Verhoye L, Farhoudi A, et al. In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus. Hepatology. 2011 Jan 11. doi: 10.1002/hep.24171. http://amedeo.com/p2.php?id=21319203 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 4. STEPANOVA M, Kanwal F, El-Serag HB, Younossi ZM, et al. Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States. Hepatology. 2010 Dec 17. doi: 10.1002/hep.24131. http://amedeo.com/p2.php?id=21319199 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available 5. VALENTI L, Rumi M, Galmozzi E, Aghemo A, et al. Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology. 2010 Dec 13. doi: 10.1002/hep.24123. http://amedeo.com/p2.php?id=21319195 & s=hep & pm=3e5d26a0f9107d3 ABSTRACT available Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.